NEONATAL METABOLIC BONE DISEASE

NEONATAL METABOLIC BONE DISEASE was reported 3 times

NEONATAL METABOLIC BONE DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
1 General Anesthetic [EPC] 1 0.0000
2 Methylxanthine [EPC] 1 0.0000
3 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
4 Glycopeptide Antibacterial [EPC] 1 0.0000
5 Catecholamine [EPC] 1 0.0000
6 Central Nervous System Stimulant [EPC] 1 0.0000
7 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
8 Prostacycline Vasodilator [EPC] 1 0.0000
9 Opioid Agonist [EPC] 1 0.0000
10 Loop Diuretic [EPC] 1 0.0000
11 Corticosteroid [EPC] 2 0.0000